Soleus Capital Management’s Affimed AFMD Stock Holding History

Soleus Capital Management’s Portfolio AFMD Stock Details AFMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-6,849	Closed	-$232K	–	66
2020 Q3	$232K	Buy	+6,849	New	+$259K	0.12%	60

Other funds holding AFMD

NMC

NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

6CM

683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

GIM

Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return

Soleus Capital Management's AFMD Position: Q4 2020 in Review

Soleus Capital Management sold out of Affimed (AFMD) in Q4 2020, closing a stake of 6,849 shares — an estimated $232K sold.

Soleus Capital Management first reported a position in AFMD in Q3 2020 and held it in 1 quarter. The position peaked at $232K in Q3 2020. 126 funds tracked by Wall St. Rank hold AFMD as of Q4 2020.

Soleus Capital Management reported no remaining Affimed position as of Q4 2020 after selling out during the quarter.
Soleus Capital Management sold 6,849 Affimed shares in Q4 2020, an estimated $232K.
Soleus Capital Management first reported a position in Affimed in Q3 2020 and held it in 1 quarter.
Soleus Capital Management's Affimed position peaked at $232K in Q3 2020.
126 funds tracked by Wall St. Rank held Affimed as of Q4 2020.

Based on Soleus Capital Management's 13F filing for Q4 2020, filed 16 Feb 2021.